{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:50:25Z","timestamp":1784001025701,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004008","name":"National Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006536","name":"Enzon Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006536","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009996","name":"Leadiant Biosciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020218","name":"Chiesi USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jaci.2024.08.014","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:04:26Z","timestamp":1724472266000},"page":"166-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evolving spectrum of adenosine deaminase (ADA) deficiency: Assessing genotype pathogenicity according to expressed ADA activity of 46 variants"],"prefix":"10.1016","volume":"155","author":[{"given":"Ines","family":"Santisteban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco X.","family":"Arredondo-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busra","family":"Dalgic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Hermanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa K.","family":"Tarrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3589-8554","authenticated-orcid":false,"given":"Michael S.","family":"Hershfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.08.014_bib1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","article-title":"Adenosine deaminase deficiency in two patients with severely impaired cellular immunity","volume":"2","author":"Giblett","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.08.014_bib2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1073\/pnas.75.1.472","article-title":"Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency","volume":"75","author":"Cohen","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2024.08.014_bib3","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0021-9258(17)34910-4","article-title":"Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency","volume":"253","author":"Coleman","year":"1978","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2024.08.014_bib4","series-title":"Primary immunodeficiency diseases: a molecular and genetic approach","first-page":"121","article-title":"Immunodeficiency disease due to deficiency of adenosine deaminase","author":"Hirschhorn","year":"1999"},{"key":"10.1016\/j.jaci.2024.08.014_bib5","series-title":"The metabolic and molecular bases of inherited disease","first-page":"2585","article-title":"Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency","author":"Hershfield","year":"2001"},{"key":"10.1016\/j.jaci.2024.08.014_bib6","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.4049\/jimmunol.153.5.2331","article-title":"Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency","volume":"153","author":"Shovlin","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib7","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1182\/blood.V89.8.2849","article-title":"Adenosine deaminase deficiency in adults","volume":"89","author":"Ozsahin","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2024.08.014_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s004390050460","article-title":"Two newly identified mutations (Thr233Ile and Leu152Met) in partially adenosine deaminase-deficient (ADA\u2212) individuals that result in differing biochemical and metabolic phenotypes","volume":"100","author":"Hirschhorn","year":"1997","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaci.2024.08.014_bib9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0022-3476(76)80792-5","article-title":"Deficiency of adenosine deaminase not associated with severe combined immunodeficiency","volume":"89","author":"Jenkins","year":"1976","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2024.08.014_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0952-7915(03)00104-3","article-title":"Genotype is an important determinant of phenotype in adenosine deaminase deficiency","volume":"15","author":"Hershfield","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib11","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/302054","article-title":"Adenosine deaminase deficiency: genotype\u2013phenotype correlations based on expressed activity of 29 mutant alleles","volume":"63","author":"Arredondo-Vega","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2024.08.014_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clim.2015.08.001","article-title":"Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: segregation of genotypes with specific ethnicities","volume":"161","author":"Adams","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12519-023-00729-3","article-title":"Delayed-onset adenosine deaminase deficiency with a novel synonymous mutation and a case series from China","volume":"19","author":"Zhang","year":"2023","journal-title":"World J Pediatr"},{"key":"10.1016\/j.jaci.2024.08.014_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10875-018-0496-9","article-title":"ADA deficiency: evaluation of the clinical and laboratory features and the outcome","volume":"38","author":"Cagdas","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib16","article-title":"Clinical, immunological, and molecular features of severe combined immune deficiency: a multi-institutional experience from India","volume":"11","author":"Vignesh","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib17","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s10875-020-00857-9","article-title":"Adenosine deaminase (ADA)-deficient severe combined immune deficiency (SCID) in the US Immunodeficiency Network (USIDNet) registry","volume":"40","author":"Kuo","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood.2022016196","article-title":"Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC","volume":"140","author":"Cuvelier","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2024.08.014_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.anai.2022.07.016","article-title":"Newborn tandem mass spectroscopy screening for adenosine deaminase deficiency","volume":"129","author":"Hartog","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib20","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jaci.2012.08.054","article-title":"Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency","volume":"131","author":"la Marca","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaci.2022.10.022","article-title":"The diagnosis of severe combined immunodeficiency (SCID): the Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 definitions","volume":"151","author":"Dvorak","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.109942","article-title":"Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia","volume":"261","author":"Abraham","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood.V99.3.1005","article-title":"Adenosine deaminase deficiency with mosaicism for a \u201csecond-site suppressor\u201d of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy","volume":"99","author":"Arredondo-Vega","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2024.08.014_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-3083.2011.02593.x","article-title":"Somatic mosaicism caused by monoallelic reversion of a mutation in T cells of a patient with ADA-SCID and the effects of enzyme replacement therapy on the revertant phenotype","volume":"74","author":"Moncada-Velez","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1172\/JCI114730","article-title":"Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combined immunodeficiency","volume":"86","author":"Arredondo-Vega","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2024.08.014_bib26","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1016\/S0021-9258(20)65152-3","article-title":"Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells","volume":"257","author":"Hershfield","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2024.08.014_bib27","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1182\/blood.V97.9.2896","article-title":"T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation","volume":"97","author":"Ariga","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2024.08.014_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ng0796-290","article-title":"Spontaneous in\u00a0vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency","volume":"13","author":"Hirschhorn","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2024.08.014_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.clim.2008.08.026","article-title":"Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient","volume":"130","author":"Liu","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib30","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1021\/bi00222a033","article-title":"Deduced amino acid sequence of Escherichia coli adenosine deaminase reveals evolutionarily conserved amino acid residues: implications for catalytic function","volume":"30","author":"Chang","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaci.2024.08.014_bib31","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.4049\/jimmunol.166.3.1698","article-title":"Molecular basis for paradoxical carriers of adenosine deaminase (ADA) deficiency that show extremely low levels of ADA activity in peripheral blood cells without immunodeficiency","volume":"166","author":"Ariga","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2141.2011.08640.x","article-title":"ADA-SCID with \u201cWAZA-ARI\u201d mutations that synergistically abolished ADA protein stability","volume":"153","author":"Okura","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2024.08.014_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"issue":"6664","key":"10.1016\/j.jaci.2024.08.014_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"issue":"7873","key":"10.1016\/j.jaci.2024.08.014_bib35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"6637","key":"10.1016\/j.jaci.2024.08.014_bib36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.ade2574","article-title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","volume":"379","author":"Lin","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jaci.2024.08.014_bib37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2004.10.012","article-title":"Development of population-based newborn screening for severe combined immunodeficiency","volume":"115","author":"Chan","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/imr.12729","article-title":"Newborn screening for severe combined immunodeficiency and T-cell lymphopenia","volume":"287","author":"Puck","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2024.08.014_bib39","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jaci.2011.03.040","article-title":"Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry","volume":"127","author":"Azzari","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jpba.2013.08.044","article-title":"The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry","volume":"88","author":"la Marca","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jaci.2024.08.014_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13073-022-01026-w","article-title":"A guide for the diagnosis of rare and undiagnosed disease: beyond the exome","volume":"14","author":"Marwaha","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.jaci.2024.08.014_bib42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-med-042921-110721","article-title":"Exome\/genome sequencing in undiagnosed syndromes","volume":"74","author":"Sullivan","year":"2023","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaci.2024.08.014_bib43","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","article-title":"Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency","volume":"143","author":"Kohn","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.08.014_bib44","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaci.2012.04.004","article-title":"Delayed-onset adenosine deaminase deficiency: strategies for an early diagnosis","volume":"130","author":"Speckmann","year":"2012","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924008649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924008649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T19:49:22Z","timestamp":1750708162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924008649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0091674924008649"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.08.014","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving spectrum of adenosine deaminase (ADA) deficiency: Assessing genotype pathogenicity according to expressed ADA activity of 46 variants","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}